Suven Pharmaceuticals

1125.15

-9.00 (-0.79%) tick

BSE

Buy Sell

NSE BSE

Last updated on 1 May 2025 04:13 PM

Open Demat account

Returns

-6.74%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

28877.85

Earning Per Share

11.97

Dividend Yield

P/E Ratio

56.52

P/B Ratio

13.09

Debt to Equity

0.04

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Suven Pharmaceuticals Limited (SPL) is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors. The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Suven Pharmaceuticals Limited was incorporated on 6 November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. The Company has established core competencies in cyanation and heterocyclic chemistry, covering pyrimidines, quinolones, thiazoles, and imidazoles. The Company is a CDMO that supports global life sciences industry and fine chemical majors in their NCE development endeavors.

Similar Companies

Laurus Labs

603.85 -13.60 (-0.02%) tick

1Yr Returns

+34.12%

Piramal Pharma Limited

211.05 -0.91 (-0.00%) tick

1Yr Returns

+47.22%

J.B.Chemicals & Pharma

1612.4 +26.90 (0.02%) tick

1Yr Returns

-14.48%

Wockhardt

1296.7 -67.00 (-0.05%) tick

1Yr Returns

+127.27%

Emcure pharmaceuticals

1021.9 +12.80 (0.01%) tick

1Yr Returns

-24.81%